Compare GLP-1 Medications
GLP-1 Medication Comparison: What are they, how they work and what to expect
Side-by-Side GLP-1 Medication Comparison
Click chart below to enlarge
Side-by-Side GLP-1 Side Effect Comparison
Click chart below to enlarge
The Big Picture Takeaway
-
Semaglutide: predictable but nausea-forward
-
Tirzepatide: best balance of efficacy + tolerability
-
Retatrutide: most powerful, but side effects are more systemic, not just GI
Semaglutide injections versus Semaglutide oral tablet*
(not available for Tirzepatide)
Semaglutide Injection vs. Pill:
What is the Real Difference?
Knowing the true differences bring clarity in understanding your weight loss options. The GLP-1 Semaglutide injection and the GLP-1 Semaglutide oral tablet* (not available for Tirzepatide), may share the same active ingredient, but they don’t deliver the same results, work the same way in your body, or fit the same lifestyle. This section breaks down the real, data-backed differences so you can stop guessing and start choosing what actually works best for your goals.
Key Differences: GLP-1 Injection vs. Oral Pill
Click chart below to enlarge
When you swallow a pill:
-
The drug is absorbed in the stomach or intestines
-
It travels through the portal vein
-
It goes directly to the liver before anywhere else
-
The liver must:
-
Break down (metabolize) a large portion of the drug
-
Convert some of it into metabolites
-
Inactivate part of the dose
-
*This is called first-pass metabolism.
Why this matters for the liver
-
The liver sees a high concentration all at once
-
It has to do more chemical processing
-
GLP-1's can be toxic or inflammatory to the liver
-
Repeated exposure can raise liver enzymes or stress liver cells
*Because of what is lost during first pass absorption, oral doses are often higher, which further increases liver workload.
Why this is gentler on the liver?
-
No first-pass metabolism
-
Lower peak concentration hitting the liver
-
Slower, steadier exposure
-
Often lower total dose needed
-
Less production of potentially harmful metabolites
With a subcutaneous injection:
-
The drug slowly enters local blood vessels or lymphatic channels
-
It circulates through the body first
-
The liver processes it later and gradually, not all at once
Oral GLP-1's *(not available for Tirzapitide):
-
Must survive stomach acid
-
Require absorption enhancers and higher doses
-
Hit the liver first at higher concentrations
-
Can increase liver enzyme elevations
-
Should be used with caution if you have fatty liver disease, intercurrent illness, alcohol, other meds as this increases the burden on the liver and increases the risk of liver damage
Pfizer discontinued development after one asymptomatic participant in a dose-optimization study had “potential drug-induced liver injury,” which resolved after stopping the drug. They discontinued development of their oral GLP-1 product.​
Injected GLP-1's:
-
Are absorbed intact
-
Mimic natural hormone signaling
-
Have minimal direct liver burden
-
Rarely cause liver injury
Subcutaneous injections bypass first-pass liver metabolism, resulting in lower peak liver exposure, less metabolic stress, and reduced risk of liver-related side effects compared to oral pills of the same medication.​
So, What is the Takeaway?
Data shows GLP-1 injections still
deliver more Consistent, Predictable & Greater weight loss today with:
​
-
Faster onset of appetite control
-
More predictable weekly weight loss
-
More stable drug levels​
GLP-1 Pills are improving, but they haven’t fully closed the gap yet with:
-
Slower ramp-up because absorption is lower
-
More GI side effects for some patients
-
Requires closer attention to dosing adherence and to hydration